Industry Research Reports
Home > Reports > Chemical & Material > Global Ligases Enzymes Market Outlook, In‑Depth Analysis & Forecast to 2031
Global Ligases Enzymes Market Outlook, In‑Depth Analysis & Forecast to 2031
Industry: Chemical & Material
Published Date: 2025-10-26
Pages: 173 Pages
Report ld: 4790901
Request Sample
Customized Report
- Description
- Table of Contents
- Table of Figures
- Related Reports
PDF Download
- Description
- Table of Contents
- Table of Figures
- Related Reports
- PDF Download
Ligases Enzymes Market Size(US$)
CAGR 2025-2031
5.8%
Market Size,2031
USD 2,876
Million
Market Snapshot
Market Size in 2025 (Value)
US$ 2,050 million
Market Forecast in 2031(Value)
US$ 2,876 million
CAGR
5.8%
Years Considered
2020-2031
Base Year
2025
Forecast Period
2025-2031
Source: Secondary research, interviews with experts, and QYResearch analysis
The global Ligases Enzymes market is projected to grow from US$ 1929 million in 2024 to US$ 2876 million by 2031, at a CAGR of 5.8% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Ligases enzymes is a type of enzyme that catalyzes the formation of phosphodiester bonds between DNA or RNA chains. It is mainly used to connect two nucleic acid fragments and is an indispensable tool enzyme in DNA repair, recombination and cloning. In molecular biology experiments, the most commonly used enzyme is T4 DNA ligase, which can efficiently connect double-stranded DNA fragments with compatible ends or blunt ends. Ligase has a wide range of applications in genetic engineering, PCR product cloning, primer ligation and synthetic biology. It is a key enzyme for fragment splicing and recombination in genetic manipulation.
The global ligase market is expanding steadily. As an indispensable basic tool enzyme in molecular biology and synthetic biology, ligase is widely used in DNA cloning, gene editing, synthetic DNA construction, NGS (high-throughput sequencing) library preparation, and RNA modification. In recent years, the demand for RNA ligase, thermostable ligase (such as Taq DNA Ligase) and high-fidelity ligase has grown rapidly, especially in high-throughput sequencing, precision medicine and mRNA vaccine technology chains. North America ranks first in the global market due to sufficient scientific research funding and concentrated biotechnology companies; the demand in the Asia-Pacific market has grown rapidly, becoming a new engine to promote overall growth.
The core driving force for the growth of the ligase market comes from increased investment in life science research, accelerated development of precision medicine, and the continuous advancement of the commercialization of synthetic biology. Especially in NGS library construction and single-cell sequencing, high-fidelity and high-efficiency ligases have become key consumables, helping to improve sequencing efficiency and data accuracy. In terms of technological evolution, ligases are developing towards stronger thermal stability, wider reaction conditions, higher ligation efficiency, and greater compatibility with non-standard ends. In addition, high-throughput ligation kits that work with automation platforms and laboratory information systems (LIMS) are also increasingly popular in the market, providing convenience for large-scale research projects and industrial applications.
Despite the good market development prospects, the industry still faces some challenges, such as the lack of complete unification of enzyme preparation quality standards, restrictions on high-end patented enzyme licensing, and high cold chain transportation and storage costs. In the future, with the implementation of emerging applications in the downstream of the synthetic biology industry chain, such as artificial chromosome construction and DNA data storage, the market value of ligases will continue to increase.
Report Includes:
This definitive report equips business leaders, decision-makers and stakeholders with a 360° view of the global Ligases Enzymes market, seamlessly integrating production capacity and sales performance across the value chain. It analyzes historical production, revenue, and sales data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.
By segmenting the market by Type and by Application, the study quantifies volume and value, growth rates, technical innovations, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.
Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries. Each region’s dominant products, competitive landscape, and downstream demand trends are clearly detailed.
Critical competitive intelligence profiles manufacturers—capacity, sales volume, revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.
A concise supply‑chain overview maps upstream suppliers, manufacturing technologies, cost structures, and distribution dynamics to identify strategic gaps and unmet demand.
MARKET SEGMENTATION
By Company
- Thermo Fisher Scientific
- QIAGEN
- Roche
- Takara
- Promega
- Vazyme
- Agilent
- New England Biolabs
- BioRad
- Fapon Biotech Inc
- Yeasen
- Abclonal
- Novoprotein
- TransGen Biotech
- Illumina, Inc.
- CWbio
Consumption by Region
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
- Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
- Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA
Segment by Type
- DNA Ligase
- RNA Ligase
Segment by Application
- Academic & Research Institutes
- Hospitals & Diagnostic Centers
- Pharmaceutical & Biotechnology Companies
- Others
CHAPTER OUTLINE
Chapter 1: Defines the Ligases Enzymes study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential.
Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts
Chapter 3: Maps global production capacity, utilization, and market share (2020–2031), identifies efficient hubs, reveals regulatory/trade policy impacts and bottlenecks.
Chapter 4: Dissects the manufacturer landscape—ranks by volume and revenue, analyzes profitability and pricing, maps production bases, details manufacturer performance by product type and evaluates concentration alongside M&A moves.
Chapter 5: Unlocks high margin product segments—compares sales, revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
Chapter 6: Targets downstream market opportunities—evaluates sales, revenue, and pricing by Application, identifies emerging use cases, and profiles leading customers by region and by Application.
Chapter 7: North America—breaks down sales and revenue by Type, by Application and country, profiles key manufacturers and assesses growth drivers and barriers.
Chapter 8: Europe—analyses regional sales, revenue and market by Type, by Application and manufacturers, flagging drivers and barriers.
Chapter 9: Asia Pacific—quantifies sales and revenue by Type, by Application, and region/country, profiles top manufacturers, and uncovers high potential expansion areas.
Chapter 10: Central & South America—measures sales and revenue by Type, by Application, and country, profiles top manufacturers, and identifies investment opportunities and challenges.
Chapter 11: Middle East and Africa—evaluates sales and revenue by Type, by Application, and country, profiles key manufacturers, and outlines investment prospects and market hurdles
Chapter 12: Profiles manufacturers in depth—details product specs, capacity, sales, revenue, margins; top manufactures 2024 sales breakdowns by product type, by Application, by sales region SWOT analysis, and recent strategic developments.
Chapter 13: Supply chain—analyses upstream raw materials and suppliers, manufacturing footprint and technology, cost drivers, plus downstream channels and distributor roles.
Chapter 14: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 15: Actionable conclusions and strategic recommendations.
WHY THIS REPORT
Beyond standard market data, this analysis provides a clear profitability roadmap, empowering you to:
Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:
Allocate capital strategically to high growth regions (Chapters 7–11) and margin rich segments (Chapter 5).
Negotiate from strength with suppliers (Chapter 13) and customers (Chapter 6) using cost and demand intelligence.
Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 4 and 12).
Secure your supply chain against disruptions through upstream and downstream visibility (Chapters 13 and 14).
Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
Market entry risks/opportunities by region
We identify regional market threats and growth prospects to guide your overseas layout.
Product mix optimization based on local practices
We adjust product portfolios in line with local consumption habits.
Competitor tactics in fragmented vs. consolidated markets
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
Full Research Coverage
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
19 Years Industry Expertise
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
24/7 Fast Report Delivery
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
Localized Strategic Analysis
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
Market entry risks/opportunities by region
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
Market entry risks/opportunities by region
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Study Coverage
1.1 Introduction to Ligases Enzymes: Definition, Properties, and Key Attributes
1.2 Market Segmentation by Type
1.2.1 Global Ligases Enzymes Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 DNA Ligase
1.2.3 RNA Ligase
1.3 Market Segmentation by Application
1.3.1 Global Ligases Enzymes Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 Academic & Research Institutes
1.3.3 Hospitals & Diagnostic Centers
1.3.4 Pharmaceutical & Biotechnology Companies
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Ligases Enzymes Revenue Estimates and Forecasts 2020-2031
2.2 Global Ligases Enzymes Revenue by Region
2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031
2.2.2 Historical and Forecasted Revenue by Region (2020--2031)
2.2.3 Global Revenue Market Share by Region (2020-2031)
2.3 Global Ligases Enzymes Sales Estimates and Forecasts 2020-2031
2.4 Global Ligases Enzymes Sales by Region
2.4.1 Sales Comparison: 2020 VS 2024 VS 2031
2.4.2 Historical and Forecasted Sales by Region (2020-2031)
2.4.3 Emerging Market Focus: Growth Drivers & Investment Trends
2.4.4 Global Sales Market Share by Region (2020-2031)
3 Global Production Analysis
3.1 Global Ligases Enzymes Production Capacity and Utilization Rates (2020–2031)
3.2 Regional Production: Comparative Analysis (2020 VS 2024 VS 2031)
3.3 Regional Production Dynamics
3.3.1 Historic Production by Region (2020-2025)
3.3.2 Forecasted Production by Region (2026-2031)
3.3.3 Production Market Share by Region (2020-2031)
3.3.4 Regulatory and Trade Policy Impact on Production
3.3.5 Production Capacity Enablers and Constraints
3.4 Key Regional Production Hubs
3.4.1 North America
3.4.2 Europe
3.4.3 China
3.4.4 Japan
4 Competition by Manufacturers
4.1 Global Ligases Enzymes Sales by Manufacturers
4.1.1 Global Sales Volume by Manufacturers (2020-2025)
4.1.2 Global Top 5 and Top 10 Manufacturers’Market Share by Sales Volume (2024)
4.2 Global Ligases Enzymes Manufacturer Revenue Rankings and Tiers
4.2.1 Global Revenue (Value) by Manufacturers (2020-2025)
4.2.2 Global Key Manufacturer Revenue Ranking (2023 vs. 2024)
4.2.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
4.3 Manufacturer Profitability Profiles and Pricing Strategies
4.3.1 Gross Margin by Top Manufacturer (2020 VS 2024)
4.3.2 Manufacturer-Level Price Trends (2020-2025)
4.4 Key Manufacturers Manufacturing Base and Headquarters
4.5 Main Product Type Market Size by Manufacturers
4.5.1 DNA Ligase Market Size by Manufacturers
4.5.2 RNA Ligase Market Size by Manufacturers
4.6 Global Ligases Enzymes Market Concentration and Dynamics
4.6.1 Global Market Concentration (CR5 and HHI)
4.6.2 Entrant/Exit Impact Analysis
4.6.3 Strategic Moves: M&A, Capacity Expansion, R&D Investment
5 Global Product Segmentation Analysis
5.1 Global Ligases Enzymes Sales Performance by Type
5.1.1 Global Historical and Forecasted Sales by Type (2020-2031)
5.1.2 Global Sales Market Share by Type (2020-2031)
5.2 Global Ligases Enzymes Revenue Trends by Type
5.2.1 Global Historical and Forecasted Revenue by Type (2020-2031)
5.2.2 Global Revenue Market Share by Type (2020-2031)
5.3 Global Average Selling Price (ASP) Trends by Type (2020-2031)
5.4 Product Technology Differentiation
5.5 Subtype Dynamics: Growth Leaders, Profitability and Risk
5.5.1 High-Growth Niches and Adoption Drivers
5.5.2 Profitability Hotspots and Cost Drivers
5.5.3 Substitution Threats
6 Global Downstream Application Analysis
6.1 Global Ligases Enzymes Sales by Application
6.1.1 Global Historical and Forecasted Sales by Application (2020-2031)
6.1.2 Global Sales Market Share by Application (2020-2031)
6.1.3 High-Growth Application Identification
6.1.4 Emerging Application Case Studies
6.2 Global Ligases Enzymes Revenue by Application
6.2.1 Global Historical and Forecasted Revenue by Application (2020-2031)
6.2.2 Revenue Market Share by Application (2020-2031)
6.3 Global Pricing Dynamics by Application (2020-2031)
6.4 Downstream Customer Analysis
6.4.1 Top Customers by Region
6.4.2 Top Customers by Application
7 North America
7.1 North America Sales Volume and Revenue (2020-2031)
7.2 North America Key Manufacturers Sales Revenue in 2024
7.3 North America Ligases Enzymes Sales and Revenue by Type (2020-2031)
7.4 North America Ligases Enzymes Sales and Revenue by Application (2020-2031)
7.5 North America Growth Accelerators and Market Barriers
7.6 North America Ligases Enzymes Market Size by Country
7.6.1 North America Revenue by Country
7.6.2 North America Sales Trends by Country
7.6.3 US
7.6.4 Canada
7.6.5 Mexico
8 Europe
8.1 Europe Sales Volume and Revenue (2020-2031)
8.2 Europe Key Manufacturers Sales Revenue in 2024
8.3 Europe Ligases Enzymes Sales and Revenue by Type (2020-2031)
8.4 Europe Ligases Enzymes Sales and Revenue by Application (2020-2031)
8.5 Europe Growth Accelerators and Market Barriers
8.6 Europe Ligases Enzymes Market Size by Country
8.6.1 Europe Revenue by Country
8.6.2 Europe Sales Trends by Country
8.6.3 Germany
8.6.4 France
8.6.5 U.K.
8.6.6 Italy
8.6.7 Russia
9 Asia-Pacific
9.1 Asia-Pacific Sales Volume and Revenue (2020-2031)
9.2 Asia-Pacific Key Manufacturers Sales Revenue in 2024
9.3 Asia-Pacific Ligases Enzymes Sales and Revenue by Type (2020-2031)
9.4 Asia-Pacific Ligases Enzymes Sales and Revenue by Application (2020-2031)
9.5 Asia-Pacific Ligases Enzymes Market Size by Region
9.5.1 Asia-Pacific Revenue by Region
9.5.2 Asia-Pacific Sales Trends by Region
9.6 Asia-Pacific Growth Accelerators and Market Barriers
9.7 Southeast Asia
9.7.1 Southeast Asia Revenue by Country (2020 VS 2024 VS 2031)
9.7.2 Key Country Analysis: Indonesia, Vietnam, Thailand
9.8 China
9.9 Japan
9.10 South Korea
9.11 China Taiwan
9.12 India
10 Central and South America
10.1 Central and South America Sales Volume and Revenue (2020-2031)
10.2 Central and South America Key Manufacturers Sales Revenue in 2024
10.3 Central and South America Ligases Enzymes Sales and Revenue by Type (2020-2031)
10.4 Central and South America Ligases Enzymes Sales and Revenue by Application (2020-2031)
10.5 Central and South America Investment Opportunities and Key Challenges
10.6 Central and South America Ligases Enzymes Market Size by Country
10.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)
10.6.2 Brazil
10.6.3 Argentina
11 Middle East and Africa
11.1 Middle East and Africa Sales Volume and Revenue (2020-2031)
11.2 Middle East and Africa Key Manufacturers Sales Revenue in 2024
11.3 Middle East and Africa Ligases Enzymes Sales and Revenue by Type (2020-2031)
11.4 Middle East and Africa Ligases Enzymes Sales and Revenue by Application (2020-2031)
11.5 Middle East and Africa Investment Opportunities and Key Challenges
11.6 Middle East and Africa Ligases Enzymes Market Size by Country
11.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)
11.6.2 GCC Countries
11.6.3 Turkey
11.6.4 Egypt
11.6.5 South Africa
12 Corporate Profile
12.1 Thermo Fisher Scientific
12.1.1 Thermo Fisher Scientific Corporation Information
12.1.2 Thermo Fisher Scientific Business Overview
12.1.3 Thermo Fisher Scientific Ligases Enzymes Product Models, Descriptions and Specifications
12.1.4 Thermo Fisher Scientific Ligases Enzymes Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.1.5 Thermo Fisher Scientific Ligases Enzymes Sales by Product in 2024
12.1.6 Thermo Fisher Scientific Ligases Enzymes Sales by Application in 2024
12.1.7 Thermo Fisher Scientific Ligases Enzymes Sales by Geographic Area in 2024
12.1.8 Thermo Fisher Scientific Ligases Enzymes SWOT Analysis
12.1.9 Thermo Fisher Scientific Recent Developments
12.2 QIAGEN
12.2.1 QIAGEN Corporation Information
12.2.2 QIAGEN Business Overview
12.2.3 QIAGEN Ligases Enzymes Product Models, Descriptions and Specifications
12.2.4 QIAGEN Ligases Enzymes Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.2.5 QIAGEN Ligases Enzymes Sales by Product in 2024
12.2.6 QIAGEN Ligases Enzymes Sales by Application in 2024
12.2.7 QIAGEN Ligases Enzymes Sales by Geographic Area in 2024
12.2.8 QIAGEN Ligases Enzymes SWOT Analysis
12.2.9 QIAGEN Recent Developments
12.3 Roche
12.3.1 Roche Corporation Information
12.3.2 Roche Business Overview
12.3.3 Roche Ligases Enzymes Product Models, Descriptions and Specifications
12.3.4 Roche Ligases Enzymes Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.3.5 Roche Ligases Enzymes Sales by Product in 2024
12.3.6 Roche Ligases Enzymes Sales by Application in 2024
12.3.7 Roche Ligases Enzymes Sales by Geographic Area in 2024
12.3.8 Roche Ligases Enzymes SWOT Analysis
12.3.9 Roche Recent Developments
12.4 Takara
12.4.1 Takara Corporation Information
12.4.2 Takara Business Overview
12.4.3 Takara Ligases Enzymes Product Models, Descriptions and Specifications
12.4.4 Takara Ligases Enzymes Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.4.5 Takara Ligases Enzymes Sales by Product in 2024
12.4.6 Takara Ligases Enzymes Sales by Application in 2024
12.4.7 Takara Ligases Enzymes Sales by Geographic Area in 2024
12.4.8 Takara Ligases Enzymes SWOT Analysis
12.4.9 Takara Recent Developments
12.5 Promega
12.5.1 Promega Corporation Information
12.5.2 Promega Business Overview
12.5.3 Promega Ligases Enzymes Product Models, Descriptions and Specifications
12.5.4 Promega Ligases Enzymes Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.5.5 Promega Ligases Enzymes Sales by Product in 2024
12.5.6 Promega Ligases Enzymes Sales by Application in 2024
12.5.7 Promega Ligases Enzymes Sales by Geographic Area in 2024
12.5.8 Promega Ligases Enzymes SWOT Analysis
12.5.9 Promega Recent Developments
12.6 Vazyme
12.6.1 Vazyme Corporation Information
12.6.2 Vazyme Business Overview
12.6.3 Vazyme Ligases Enzymes Product Models, Descriptions and Specifications
12.6.4 Vazyme Ligases Enzymes Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.6.5 Vazyme Recent Developments
12.7 Agilent
12.7.1 Agilent Corporation Information
12.7.2 Agilent Business Overview
12.7.3 Agilent Ligases Enzymes Product Models, Descriptions and Specifications
12.7.4 Agilent Ligases Enzymes Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.7.5 Agilent Recent Developments
12.8 New England Biolabs
12.8.1 New England Biolabs Corporation Information
12.8.2 New England Biolabs Business Overview
12.8.3 New England Biolabs Ligases Enzymes Product Models, Descriptions and Specifications
12.8.4 New England Biolabs Ligases Enzymes Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.8.5 New England Biolabs Recent Developments
12.9 BioRad
12.9.1 BioRad Corporation Information
12.9.2 BioRad Business Overview
12.9.3 BioRad Ligases Enzymes Product Models, Descriptions and Specifications
12.9.4 BioRad Ligases Enzymes Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.9.5 BioRad Recent Developments
12.10 Fapon Biotech Inc
12.10.1 Fapon Biotech Inc Corporation Information
12.10.2 Fapon Biotech Inc Business Overview
12.10.3 Fapon Biotech Inc Ligases Enzymes Product Models, Descriptions and Specifications
12.10.4 Fapon Biotech Inc Ligases Enzymes Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.10.5 Fapon Biotech Inc Recent Developments
12.11 Yeasen
12.11.1 Yeasen Corporation Information
12.11.2 Yeasen Business Overview
12.11.3 Yeasen Ligases Enzymes Product Models, Descriptions and Specifications
12.11.4 Yeasen Ligases Enzymes Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.11.5 Yeasen Recent Developments
12.12 Abclonal
12.12.1 Abclonal Corporation Information
12.12.2 Abclonal Business Overview
12.12.3 Abclonal Ligases Enzymes Product Models, Descriptions and Specifications
12.12.4 Abclonal Ligases Enzymes Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.12.5 Abclonal Recent Developments
12.13 Novoprotein
12.13.1 Novoprotein Corporation Information
12.13.2 Novoprotein Business Overview
12.13.3 Novoprotein Ligases Enzymes Product Models, Descriptions and Specifications
12.13.4 Novoprotein Ligases Enzymes Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.13.5 Novoprotein Recent Developments
12.14 TransGen Biotech
12.14.1 TransGen Biotech Corporation Information
12.14.2 TransGen Biotech Business Overview
12.14.3 TransGen Biotech Ligases Enzymes Product Models, Descriptions and Specifications
12.14.4 TransGen Biotech Ligases Enzymes Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.14.5 TransGen Biotech Recent Developments
12.15 Illumina, Inc.
12.15.1 Illumina, Inc. Corporation Information
12.15.2 Illumina, Inc. Business Overview
12.15.3 Illumina, Inc. Ligases Enzymes Product Models, Descriptions and Specifications
12.15.4 Illumina, Inc. Ligases Enzymes Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.15.5 Illumina, Inc. Recent Developments
12.16 CWbio
12.16.1 CWbio Corporation Information
12.16.2 CWbio Business Overview
12.16.3 CWbio Ligases Enzymes Product Models, Descriptions and Specifications
12.16.4 CWbio Ligases Enzymes Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.16.5 CWbio Recent Developments
13 Value Chain and Supply-Chain Analysis
13.1 Ligases Enzymes Industry Chain
13.2 Ligases Enzymes Upstream Materials Analysis
13.2.1 Raw Materials
13.2.2 Key Suppliers Market Share & Risk Assessment
13.3 Ligases Enzymes Integrated Production Analysis
13.3.1 Manufacturing Footprint Analysis
13.3.2 Production Technology Overview
13.3.3 Regional Cost Drivers
13.4 Ligases Enzymes Sales Channels and Distribution Networks
13.4.1 Sales Channels
13.4.2 Distributors
14 Ligases Enzymes Market Dynamics
14.1 Industry Trends and Evolution
14.2 Market Growth Drivers and Emerging Opportunities
14.3 Market Challenges, Risks, and Restraints
15 Key Findings in the Global Ligases Enzymes Study
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.1.1 Research Programs/Design
16.1.1.2 Market Size Estimation
16.1.1.3 Market Breakdown and Data Triangulation
16.1.2 Data Source
16.1.2.1 Secondary Sources
16.1.2.2 Primary Sources
16.2 Author Details
TABLE OF FIGURES
List of Tables
Table 1. Global Ligases Enzymes Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Table 2. Global Ligases Enzymes Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Table 3. Global Ligases Enzymes Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 4. Global Ligases Enzymes Revenue by Region (2020-2025) & (US$ Million)
Table 5. Global Ligases Enzymes Revenue by Region (2026-2031) & (US$ Million)
Table 6. Global Ligases Enzymes Sales Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (Kg)
Table 7. Global Ligases Enzymes Sales by Region (2020-2025) & (Kg)
Table 8. Global Ligases Enzymes Sales by Region (2026-2031) & (Kg)
Table 9. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 10. Global Ligases Enzymes Production Growth Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (Kg)
Table 11. Global Ligases Enzymes Production by Region (2020-2025) & (Kg)
Table 12. Global Ligases Enzymes Production by Region (2026-2031) & (Kg)
Table 13. Global Ligases Enzymes Sales by Manufacturers (2020-2025) & (Kg)
Table 14. Global Ligases Enzymes Sales Share by Manufacturers (2020-2025)
Table 15. Global Ligases Enzymes Revenue by Manufacturers (2020-2025) & (US$ Million)
Table 16. Global Ligases Enzymes Revenue Market Share by Manufacturers (2020-2025)
Table 17. Global Key Manufacturers’Ranking Shift (2023 vs. 2024) (Based on Revenue)
Table 18. Global Ligases Enzymes by Manufacturer Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Ligases Enzymes as of 2024)
Table 19. Global Ligases Enzymes Average Gross Margin (%) by Manufacturer (2020 VS 2024)
Table 20. Global Ligases Enzymes Average Selling Price (ASP) by Manufacturers (2020-2025) & (USD/g)
Table 21. Key Manufacturers Ligases Enzymes Manufacturing Base and Headquarters
Table 22. Global Ligases Enzymes Market Concentration Ratio (CR5 and HHI)
Table 23. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis
Table 24. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
Table 25. Global Ligases Enzymes Sales by Type (2020-2025) & (Kg)
Table 26. Global Ligases Enzymes Sales by Type (2026-2031) & (Kg)
Table 27. Global Ligases Enzymes Revenue by Type (2020-2025) & (US$ Million)
Table 28. Global Ligases Enzymes Revenue by Type (2026-2031) & (US$ Million)
Table 29. Global Ligases Enzymes ASP by Type (2020-2031) & (USD/g)
Table 30. Technical Specifications by Key Product Type
Table 31. Global Ligases Enzymes Sales by Application (2020-2025) & (Kg)
Table 32. Global Ligases Enzymes Sales by Application (2026-2031) & (Kg)
Table 33. Ligases Enzymes High-Growth Sectors Demand CAGR (2024-2031)
Table 34. Global Ligases Enzymes Revenue by Application (2020-2025) & (US$ Million)
Table 35. Global Ligases Enzymes Revenue by Application (2026-2031) & (US$ Million)
Table 36. Global Ligases Enzymes ASP by Application (2020-2031) & (USD/g)
Table 37. Top Customers by Region
Table 38. Top Customers by Application
Table 39. North America Ligases Enzymes Growth Accelerators and Market Barriers
Table 40. North America Ligases Enzymes Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 41. North America Ligases Enzymes Sales (Kg) by Country (2020 VS 2024 VS 2031)
Table 42. Europe Ligases Enzymes Growth Accelerators and Market Barriers
Table 43. Europe Ligases Enzymes Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 44. Europe Ligases Enzymes Sales (Kg) by Country (2020 VS 2024 VS 2031)
Table 45. Asia-Pacific Ligases Enzymes Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Asia-Pacific Ligases Enzymes Sales (Kg) by Country (2020 VS 2024 VS 2031)
Table 47. Asia-Pacific Ligases Enzymes Growth Accelerators and Market Barriers
Table 48. Southeast Asia Ligases Enzymes Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 49. Central and South America Ligases Enzymes Investment Opportunities and Key Challenges
Table 50. Central and South America Ligases Enzymes Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 51. Middle East and Africa Ligases Enzymes Investment Opportunities and Key Challenges
Table 52. Middle East and Africa Ligases Enzymes Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 53. Thermo Fisher Scientific Corporation Information
Table 54. Thermo Fisher Scientific Description and Major Businesses
Table 55. Thermo Fisher Scientific Product Models, Descriptions and Specifications
Table 56. Thermo Fisher Scientific Capacity, Sales (Kg), Revenue (US$ Million), Price (USD/g) and Gross Margin (2020-2025)
Table 57. Thermo Fisher Scientific Sales Value Proportion by Product in 2024
Table 58. Thermo Fisher Scientific Sales Value Proportion by Application in 2024
Table 59. Thermo Fisher Scientific Sales Value Proportion by Geographic Area in 2024
Table 60. Thermo Fisher Scientific Ligases Enzymes SWOT Analysis
Table 61. Thermo Fisher Scientific Recent Developments
Table 62. QIAGEN Corporation Information
Table 63. QIAGEN Description and Major Businesses
Table 64. QIAGEN Product Models, Descriptions and Specifications
Table 65. QIAGEN Capacity, Sales (Kg), Revenue (US$ Million), Price (USD/g) and Gross Margin (2020-2025)
Table 66. QIAGEN Sales Value Proportion by Product in 2024
Table 67. QIAGEN Sales Value Proportion by Application in 2024
Table 68. QIAGEN Sales Value Proportion by Geographic Area in 2024
Table 69. QIAGEN Ligases Enzymes SWOT Analysis
Table 70. QIAGEN Recent Developments
Table 71. Roche Corporation Information
Table 72. Roche Description and Major Businesses
Table 73. Roche Product Models, Descriptions and Specifications
Table 74. Roche Capacity, Sales (Kg), Revenue (US$ Million), Price (USD/g) and Gross Margin (2020-2025)
Table 75. Roche Sales Value Proportion by Product in 2024
Table 76. Roche Sales Value Proportion by Application in 2024
Table 77. Roche Sales Value Proportion by Geographic Area in 2024
Table 78. Roche Ligases Enzymes SWOT Analysis
Table 79. Roche Recent Developments
Table 80. Takara Corporation Information
Table 81. Takara Description and Major Businesses
Table 82. Takara Product Models, Descriptions and Specifications
Table 83. Takara Capacity, Sales (Kg), Revenue (US$ Million), Price (USD/g) and Gross Margin (2020-2025)
Table 84. Takara Sales Value Proportion by Product in 2024
Table 85. Takara Sales Value Proportion by Application in 2024
Table 86. Takara Sales Value Proportion by Geographic Area in 2024
Table 87. Takara Ligases Enzymes SWOT Analysis
Table 88. Takara Recent Developments
Table 89. Promega Corporation Information
Table 90. Promega Description and Major Businesses
Table 91. Promega Product Models, Descriptions and Specifications
Table 92. Promega Capacity, Sales (Kg), Revenue (US$ Million), Price (USD/g) and Gross Margin (2020-2025)
Table 93. Promega Sales Value Proportion by Product in 2024
Table 94. Promega Sales Value Proportion by Application in 2024
Table 95. Promega Sales Value Proportion by Geographic Area in 2024
Table 96. Promega Ligases Enzymes SWOT Analysis
Table 97. Promega Recent Developments
Table 98. Vazyme Corporation Information
Table 99. Vazyme Description and Major Businesses
Table 100. Vazyme Product Models, Descriptions and Specifications
Table 101. Vazyme Capacity, Sales (Kg), Revenue (US$ Million), Price (USD/g) and Gross Margin (2020-2025)
Table 102. Vazyme Recent Developments
Table 103. Agilent Corporation Information
Table 104. Agilent Description and Major Businesses
Table 105. Agilent Product Models, Descriptions and Specifications
Table 106. Agilent Capacity, Sales (Kg), Revenue (US$ Million), Price (USD/g) and Gross Margin (2020-2025)
Table 107. Agilent Recent Developments
Table 108. New England Biolabs Corporation Information
Table 109. New England Biolabs Description and Major Businesses
Table 110. New England Biolabs Product Models, Descriptions and Specifications
Table 111. New England Biolabs Capacity, Sales (Kg), Revenue (US$ Million), Price (USD/g) and Gross Margin (2020-2025)
Table 112. New England Biolabs Recent Developments
Table 113. BioRad Corporation Information
Table 114. BioRad Description and Major Businesses
Table 115. BioRad Product Models, Descriptions and Specifications
Table 116. BioRad Capacity, Sales (Kg), Revenue (US$ Million), Price (USD/g) and Gross Margin (2020-2025)
Table 117. BioRad Recent Developments
Table 118. Fapon Biotech Inc Corporation Information
Table 119. Fapon Biotech Inc Description and Major Businesses
Table 120. Fapon Biotech Inc Product Models, Descriptions and Specifications
Table 121. Fapon Biotech Inc Capacity, Sales (Kg), Revenue (US$ Million), Price (USD/g) and Gross Margin (2020-2025)
Table 122. Fapon Biotech Inc Recent Developments
Table 123. Yeasen Corporation Information
Table 124. Yeasen Description and Major Businesses
Table 125. Yeasen Product Models, Descriptions and Specifications
Table 126. Yeasen Capacity, Sales (Kg), Revenue (US$ Million), Price (USD/g) and Gross Margin (2020-2025)
Table 127. Yeasen Recent Developments
Table 128. Abclonal Corporation Information
Table 129. Abclonal Description and Major Businesses
Table 130. Abclonal Product Models, Descriptions and Specifications
Table 131. Abclonal Capacity, Sales (Kg), Revenue (US$ Million), Price (USD/g) and Gross Margin (2020-2025)
Table 132. Abclonal Recent Developments
Table 133. Novoprotein Corporation Information
Table 134. Novoprotein Description and Major Businesses
Table 135. Novoprotein Product Models, Descriptions and Specifications
Table 136. Novoprotein Capacity, Sales (Kg), Revenue (US$ Million), Price (USD/g) and Gross Margin (2020-2025)
Table 137. Novoprotein Recent Developments
Table 138. TransGen Biotech Corporation Information
Table 139. TransGen Biotech Description and Major Businesses
Table 140. TransGen Biotech Product Models, Descriptions and Specifications
Table 141. TransGen Biotech Capacity, Sales (Kg), Revenue (US$ Million), Price (USD/g) and Gross Margin (2020-2025)
Table 142. TransGen Biotech Recent Developments
Table 143. Illumina, Inc. Corporation Information
Table 144. Illumina, Inc. Description and Major Businesses
Table 145. Illumina, Inc. Product Models, Descriptions and Specifications
Table 146. Illumina, Inc. Capacity, Sales (Kg), Revenue (US$ Million), Price (USD/g) and Gross Margin (2020-2025)
Table 147. Illumina, Inc. Recent Developments
Table 148. CWbio Corporation Information
Table 149. CWbio Description and Major Businesses
Table 150. CWbio Product Models, Descriptions and Specifications
Table 151. CWbio Capacity, Sales (Kg), Revenue (US$ Million), Price (USD/g) and Gross Margin (2020-2025)
Table 152. CWbio Recent Developments
Table 153. Key Raw Materials Distribution
Table 154. Raw Materials Key Suppliers
Table 155. Critical Raw Material Supplier Concentration (2024) & Risk Index
Table 156. Milestones in Production Technology Evolution
Table 157. Distributors List
Table 158. Market Trends and Market Evolution
Table 159. Market Drivers and Opportunities
Table 160. Market Challenges, Risks, and Restraints
Table 161. Research Programs/Design for This Report
Table 162. Key Data Information from Secondary Sources
Table 163. Key Data Information from Primary Sources
List of Figures
Figure 1. Ligases Enzymes Product Picture
Figure 2. Global Ligases Enzymes Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Figure 3. DNA Ligase Product Picture
Figure 4. RNA Ligase Product Picture
Figure 5. Global Ligases Enzymes Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Figure 6. Academic & Research Institutes
Figure 7. Hospitals & Diagnostic Centers
Figure 8. Pharmaceutical & Biotechnology Companies
Figure 9. Others
Figure 10. Ligases Enzymes Report Years Considered
Figure 11. Global Ligases Enzymes Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 12. Global Ligases Enzymes Revenue (2020-2031) & (US$ Million)
Figure 13. Global Ligases Enzymes Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Figure 14. Global Ligases Enzymes Revenue Market Share by Region (2020-2031)
Figure 15. Global Ligases Enzymes Sales (2020-2031) & (Kg)
Figure 16. Global Ligases Enzymes Sales (CAGR) by Region (2020-2031) (Kg)
Figure 17. Global Ligases Enzymes Sales Market Share by Region (2020-2031)
Figure 18. Global Ligases Enzymes Capacity, Production and Utilization (2020-2031) & (Kg)
Figure 19. Global Ligases Enzymes Production Trend by Region (2020-2031) (Kg)
Figure 20. Global Ligases Enzymes Production Market Share by Region (2020-2031)
Figure 21. Production Capacity Enablers & Constraints
Figure 22. Ligases Enzymes Production Growth Rate in North America (2020-2031) & (Kg)
Figure 23. Ligases Enzymes Production Growth Rate in Europe (2020-2031) & (Kg)
Figure 24. Ligases Enzymes Production Growth Rate in China (2020-2031) & (Kg)
Figure 25. Ligases Enzymes Production Growth Rate in Japan (2020-2031) & (Kg)
Figure 26. Top 5 and Top 10 Manufacturers Ligases Enzymes Sales Volume Market Share in 2024
Figure 27. Global Ligases Enzymes Revenue Market Share Ranking (2024)
Figure 28. Tier Distribution by Revenue Contribution (2020 VS 2024)
Figure 29. DNA Ligase Revenue Market Share by Manufacturer in 2024
Figure 30. RNA Ligase Revenue Market Share by Manufacturer in 2024
Figure 31. Type Eight Revenue Market Share by Manufacturer in 2024
Figure 32. Type Nine Revenue Market Share by Manufacturer in 2024
Figure 33. Global Ligases Enzymes Sales Market Share by Type (2020-2031)
Figure 34. Global Ligases Enzymes Revenue Market Share by Type (2020-2031)
Figure 35. Global Ligases Enzymes Sales Market Share by Application (2020-2031)
Figure 36. Global Ligases Enzymes Revenue Market Share by Application (2020-2031)
Figure 37. North America Ligases Enzymes Sales YoY (2020-2031) & (Kg)
Figure 38. North America Ligases Enzymes Revenue YoY (2020-2031) & (US$ Million)
Figure 39. North America Top 5 Manufacturers Ligases Enzymes Sales Revenue (US$ Million) in 2024
Figure 40. North America Ligases Enzymes Sales Volume (Kg) by Type (2020- 2031)
Figure 41. North America Ligases Enzymes Sales Revenue (US$ Million) by Type (2020 - 2031)
Figure 42. North America Ligases Enzymes Sales Volume (Kg) by Application (2020-2031)
Figure 43. North America Ligases Enzymes Sales Revenue (US$ Million) by Application (2020-2031)
Figure 44. US Ligases Enzymes Revenue (2020-2031) & (US$ Million)
Figure 45. Canada Ligases Enzymes Revenue (2020-2031) & (US$ Million)
Figure 46. Mexico Ligases Enzymes Revenue (2020-2031) & (US$ Million)
Figure 47. Europe Ligases Enzymes Sales YoY (2020-2031) & (Kg)
Figure 48. Europe Ligases Enzymes Revenue YoY (2020-2031) & (US$ Million)
Figure 49. Europe Top 5 Manufacturers Ligases Enzymes Sales Revenue (US$ Million) in 2024
Figure 50. Europe Ligases Enzymes Sales Volume (Kg) by Type (2020-2031)
Figure 51. Europe Ligases Enzymes Sales Revenue (US$ Million) by Type (2020-2031)
Figure 52. Europe Ligases Enzymes Sales Volume (Kg) by Application (2020-2031)
Figure 53. Europe Ligases Enzymes Sales Revenue (US$ Million) by Application (2020-2031)
Figure 54. Germany Ligases Enzymes Revenue (2020-2031) & (US$ Million)
Figure 55. France Ligases Enzymes Revenue (2020-2031) & (US$ Million)
Figure 56. U.K. Ligases Enzymes Revenue (2020-2031) & (US$ Million)
Figure 57. Italy Ligases Enzymes Revenue (2020-2031) & (US$ Million)
Figure 58. Russia Ligases Enzymes Revenue (2020-2031) & (US$ Million)
Figure 59. Asia-Pacific Ligases Enzymes Sales YoY (2020-2031) & (Kg)
Figure 60. Asia-Pacific Ligases Enzymes Revenue YoY (2020-2031) & (US$ Million)
Figure 61. Asia-Pacific Top 8 Manufacturers Ligases Enzymes Sales Revenue (US$ Million) in 2024
Figure 62. Asia-Pacific Ligases Enzymes Sales Volume (Kg) by Type (2020- 2031)
Figure 63. Asia-Pacific Ligases Enzymes Sales Revenue (US$ Million) by Type (2020- 2031)
Figure 64. Asia-Pacific Ligases Enzymes Sales Volume (Kg) by Application (2020-2031)
Figure 65. Asia-Pacific Ligases Enzymes Sales Revenue (US$ Million) by Application (2020-2031)
Figure 66. Indonesia Ligases Enzymes Revenue (2020-2031) & (US$ Million)
Figure 67. Japan Ligases Enzymes Revenue (2020-2031) & (US$ Million)
Figure 68. South Korea Ligases Enzymes Revenue (2020-2031) & (US$ Million)
Figure 69. China Taiwan Ligases Enzymes Revenue (2020-2031) & (US$ Million)
Figure 70. India Ligases Enzymes Revenue (2020-2031) & (US$ Million)
Figure 71. Central and South America Ligases Enzymes Sales YoY (2020-2031) & (Kg)
Figure 72. Central and South America Ligases Enzymes Revenue YoY (2020-2031) & (US$ Million)
Figure 73. Central and South America Top 5 Manufacturers Ligases Enzymes Sales Revenue (US$ Million) in 2024
Figure 74. Central and South America Ligases Enzymes Sales Volume (Kg) by Type (2021-2031)
Figure 75. Central and South America Ligases Enzymes Sales Revenue (US$ Million) by Type (2020-2031)
Figure 76. Central and South America Ligases Enzymes Sales Volume (Kg) by Application (2020-2031)
Figure 77. Central and South America Ligases Enzymes Sales Revenue (US$ Million) by Application (2020-2031)
Figure 78. Brazil Ligases Enzymes Revenue (2020-2025) & (US$ Million)
Figure 79. Argentina Ligases Enzymes Revenue (2020-2025) & (US$ Million)
Figure 80. Middle East, and Africa Ligases Enzymes Sales YoY (2020-2031) & (Kg)
Figure 81. Middle East and Africa Ligases Enzymes Revenue YoY (2020-2031) & (US$ Million)
Figure 82. Middle East and Africa Top 5 Manufacturers Ligases Enzymes Sales Revenue (US$ Million) in 2024
Figure 83. Middle East and Africa Ligases Enzymes Sales Volume (Kg) by Type (2021-2031)
Figure 84. South America Ligases Enzymes Sales Revenue (US$ Million) by Type (2020-2031)
Figure 85. Middle East and Africa Ligases Enzymes Sales Volume (Kg) by Application (2020-2031)
Figure 86. Middle East and Africa Ligases Enzymes Sales Revenue (US$ Million) by Application (2020-2031)
Figure 87. GCC Countries Ligases Enzymes Revenue (2020-2025) & (US$ Million)
Figure 88. Turkey Ligases Enzymes Revenue (2020-2025) & (US$ Million)
Figure 89. Egypt Ligases Enzymes Revenue (2020-2025) & (US$ Million)
Figure 90. South Africa Ligases Enzymes Revenue (2020-2025) & (US$ Million)
Figure 91. Ligases Enzymes Industry Chain Mapping
Figure 92. Regional Ligases Enzymes Manufacturing Base Distribution (%)
Figure 93. Ligases Enzymes Production Process
Figure 94. Regional Ligases Enzymes Production Cost Structure
Figure 95. Channels of Distribution (Direct Vs Distribution)
Figure 96. Bottom-up and Top-down Approaches for This Report
Figure 97. Data Triangulation
Figure 98. Key Executives Interviewed
KEY QUESTIONS ADDRESSED BY THE REPORT
What was the global market size of Ligases Enzymes in 2025?
The global market size of Ligases Enzymes in 2025 was 2050 Million USD.
What is the annual compound growth rate of the global Ligases Enzymes market size from 2025 to 2031?
Which companies rank high in the global Ligases Enzymes market?
What was the global market size of Ligases Enzymes in 2031?
Which region is expected to have the highest market share?
Related Reports
Global Ligases Enzymes Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Ligases Enzymes market size was US$ 2050 million in 2025 and is forecast to reach a readjusted size of US$ 3026 million by 2032 with a CAGR of 5.8% during the forecast period 2026-2032.
Published Date: 2026-03-09
Pages: 101
USD 4250.00
(Single User License)
Global Ligases Enzymes Market Outlook, In‑Depth Analysis & Forecast to 2032
The global Ligases Enzymes market is projected to grow from US$ 2050 million in 2025 to US$ 3026 million by 2032, at a CAGR of 5.8% (2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2026-03-09
Pages: 179
USD 4900.00
(Single User License)
Ligases Enzymes- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Ligases Enzymes was estimated to be worth US$ 2050 million in 2025 and is projected to reach US$ 3026 million, growing at a CAGR of 5.8% from 2026 to 2032.
Published Date: 2026-03-05
Pages: 149
USD 3950.00
(Single User License)
Global Ligases Enzymes Market Research Report 2026
The global Ligases Enzymes market was valued at US$ 2050 million in 2025 and is anticipated to reach US$ 3026 million by 2032, at a CAGR of 5.8% from 2026 to 2032.
Published Date: 2026-03-05
Pages: 147
USD 2900.00
(Single User License)
Ligases Enzymes - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Ligases Enzymes was estimated to be worth US$ 1929 million in 2024 and is forecast to a readjusted size of US$ 2876 million by 2031 with a CAGR of 5.8% during the forecast period 2025-2031.
Published Date: 2025-07-13
Pages: 136
USD 3950.00
(Single User License)
Global Ligases Enzymes Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Ligases Enzymes market size was US$ 1929 million in 2024 and is forecast to a readjusted size of US$ 2876 million by 2031 with a CAGR of 5.8% during the forecast period 2025-2031.
Published Date: 2025-07-13
Pages: 104
USD 4250.00
(Single User License)
Global Ligases Enzymes Market Research Report 2025
The global market for Ligases Enzymes was valued at US$ 1929 million in the year 2024 and is projected to reach a revised size of US$ 2876 million by 2031, growing at a CAGR of 5.8% during the forecast period.
Published Date: 2025-07-13
Pages: 112
USD 2900.00
(Single User License)
Ligases Enzymes- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Ligases Enzymes was estimated to be worth US$ 434 million in 2024 and is forecast to a readjusted size of US$ 641 million by 2031 with a CAGR of 5.8% during the forecast period 2025-2031.
Published Date: 2025-02-24
Pages: 120
USD 3950.00
(Single User License)
Global Ligases Enzymes Market Insights, Forecast to 2030
Ligases enzymes are enzymes that catalyze the forming of new chemical bonds bwteeen two large molecules.
Published Date: 2024-04-26
Pages: 113
USD 4900.00
(Single User License)
Global Ligases Enzymes Market Research Report 2024
Ligases enzymes are enzymes that catalyze the forming of new chemical bonds bwteeen two large molecules.
Published Date: 2024-01-31
Pages: 97
USD 2900.00
(Single User License)
Global Ligases Enzymes Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Ligases Enzymes market size was US$ 2050 million in 2025 and is forecast to reach a readjusted size of US$ 3026 million by 2032 with a CAGR of 5.8% during the forecast period 2026-2032.
Published: 2026-03-09
Pages: 101
USD 4250.00 (Single User License)Global Ligases Enzymes Market Outlook, In‑Depth Analysis & Forecast to 2032
The global Ligases Enzymes market is projected to grow from US$ 2050 million in 2025 to US$ 3026 million by 2032, at a CAGR of 5.8% (2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2026-03-09
Pages: 179
USD 4900.00 (Single User License)Ligases Enzymes- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Ligases Enzymes was estimated to be worth US$ 2050 million in 2025 and is projected to reach US$ 3026 million, growing at a CAGR of 5.8% from 2026 to 2032.
Published: 2026-03-05
Pages: 149
USD 3950.00 (Single User License)Global Ligases Enzymes Market Research Report 2026
The global Ligases Enzymes market was valued at US$ 2050 million in 2025 and is anticipated to reach US$ 3026 million by 2032, at a CAGR of 5.8% from 2026 to 2032.
Published: 2026-03-05
Pages: 147
USD 2900.00 (Single User License)Ligases Enzymes - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Ligases Enzymes was estimated to be worth US$ 1929 million in 2024 and is forecast to a readjusted size of US$ 2876 million by 2031 with a CAGR of 5.8% during the forecast period 2025-2031.
Published: 2025-07-13
Pages: 136
USD 3950.00 (Single User License)Global Ligases Enzymes Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Ligases Enzymes market size was US$ 1929 million in 2024 and is forecast to a readjusted size of US$ 2876 million by 2031 with a CAGR of 5.8% during the forecast period 2025-2031.
Published: 2025-07-13
Pages: 104
USD 4250.00 (Single User License)Global Ligases Enzymes Market Research Report 2025
The global market for Ligases Enzymes was valued at US$ 1929 million in the year 2024 and is projected to reach a revised size of US$ 2876 million by 2031, growing at a CAGR of 5.8% during the forecast period.
Published: 2025-07-13
Pages: 112
USD 2900.00 (Single User License)Ligases Enzymes- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Ligases Enzymes was estimated to be worth US$ 434 million in 2024 and is forecast to a readjusted size of US$ 641 million by 2031 with a CAGR of 5.8% during the forecast period 2025-2031.
Published: 2025-02-24
Pages: 120
USD 3950.00 (Single User License)Global Ligases Enzymes Market Insights, Forecast to 2030
Ligases enzymes are enzymes that catalyze the forming of new chemical bonds bwteeen two large molecules.
Published: 2024-04-26
Pages: 113
USD 4900.00 (Single User License)Global Ligases Enzymes Market Research Report 2024
Ligases enzymes are enzymes that catalyze the forming of new chemical bonds bwteeen two large molecules.
Published: 2024-01-31
Pages: 97
USD 2900.00 (Single User License)
CHOOSE LICENSE TYPE
USD 4900.00
USD 7350.00
USD 9800.00
Add to Cart
Buy Now
HAVE A QUESTION?
General Email:
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
WHY THIS REPORT
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now